sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com
Patient Information Leaflet last updated on the eMC: 22/07/2009
PIL Adenoscan

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/07/2009 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 27/07/2006 and displayed until 22/07/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 11/05/2004 and displayed until 27/07/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 16/10/2002 and displayed until 11/05/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   adenosine


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk